Tarsus Pharmaceuticals
TARS
TARS
105 hedge funds and large institutions have $529M invested in Tarsus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
14% more funds holding
Funds holding: 92 → 105 (+13)
11.35% more ownership
Funds ownership: 79.98% → 91.33% (+11%)
Holders
105
Holding in Top 10
5
Calls
$577K
Puts
$308K
Top Buyers
| 1 | +$21.3M | |
| 2 | +$20.3M | |
| 3 | +$13.4M | |
| 4 |
Millennium Management
New York
|
+$13.1M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$9.21M |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$2.64M | |
| 3 | -$2.34M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$853K |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$852K |